Novo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its ...

Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to ...

A medical device company has secured investment from the owner of the developer of Ozempic and a private equity firm, to ...